Chile boosts minimum age for AstraZeneca COVID-19 vaccine to 45 after blood clot report

Chile boosts minimum age for AstraZeneca COVID-19 vaccine to 45 after blood clot report

FILE PHOTO: Picture illustration of a vial labelled with the AstraZeneca coronavirus disease (COVID
FILE PHOTO: A vial labelled with the AstraZeneca coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration

SANTIAGO: Chile's health ministry said Thursday (Jun 3) it would raise the minimum age of men approved to receive the AstraZeneca coronavirus vaccine to 45, from 18, until authorities complete an investigation into a young man who had a blood clot after his first shot.

Chile, a global leader in vaccinating its citizens against the virus, received its first doses of the AstraZeneca-Oxford University vaccine in April. Regulators initially approved the vaccine for men over 18 and women over 45.

Authorities said a case of thrombosis in a 31-year man prompted them to increase the minimum age, calling it a "preventive and proactive measure".

AstraZeneca's vaccine, approved in dozens of countries except the United States, has been under increased scrutiny over reports of extremely rare but serious blood clots in some people who received the vaccine.

Chilean investigators said in April they had found no instances of blood clots among the 2,200 participants who took place in an AstraZeneca clinical trial in the South American nation.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Bookmark